Abstract
The aim of the current study was to describe the incidence of respiratory symptoms and allergic sensitisation and the sequence of events leading to respiratory symptoms among Danish baker apprentices (BA). A total of 114 BA were surveyed over a 20-month period. Questionnaires were completed along with spirometric analysis and skin-prick tests to common and work-related allergens. Bronchial hyperresponsiveness (BHR) was determined at baseline and at the end of the follow-up period.
The incidences of work-related rhinitis and asthma-like symptoms were 22.1 and 10.0 cases·100 person-yrs−1, respectively. At 20 months the cumulative incidence proportion was 40.2 and 20.5% for rhinitis and asthma-like symptoms, respectively. The cumulative incidence of occupational sensitisation was 6.1%.
An increased risk of asthma-like symptoms was found in both atopic subjects and in females. In the BA with new onset respiratory symptoms, an increase in BHR from baseline was observed. Forced expiratory volume in one second and forced vital capacity did not change during the follow-up period. No relationship was observed between new sensitisation and new symptoms.
In conclusion rhinitis- and asthma-like symptoms were found to develop commonly in Danish baker apprentices. The mechanism by which symptoms arose was perceived to reflect the development of an inflammation rather than the production of a specific immunoglobulin E pathway, as sensitisation to occupational allergens was rarely observed. Hence, respiratory symptoms and allergy may develop through separate pathways.
Occupational exposures are important contributing factors in 5–19% of all cases of adult asthma 1. Bakers have the highest incidence of occupational asthma. The national yearly incidence rates vary between 28.5 cases·100 person-yrs−1 2 in the UK and 400 cases·100 person-yrs−1 3 in Finland. This is probably due to differing registration practices and diagnostic procedures 4.
The prevalence and the risk factor for baker's asthma and rhinitis have mainly been evaluated in cross-sectional studies. Reported prevalence of asthma and rhinitis has been in the range of 4–14 and 14–29%, respectively 5. In a Danish cross-sectional study the prevalence of baker’s asthma was 5% and the prevalence of sneezing, runny nose and blockage of the nose was 39.5, 27.2 and 28.6%, respectively 6. None of the studies distinguished between work-aggravated asthma and rhinitis and new-onset asthma and rhinitis. The aim of the present study was to investigate this in more detail.
The primary allergens in bakeries are components of wheat- and rye-flour proteins including α-amylase 7, 8. In a recent study, ∼60% of bakers seeking compensation for work-related respiratory symptoms were sensitised to wheat or rye flour and 22% had immunoglobulin (Ig)E antibodies to α-amylase 9.
The relationship between exposure to allergens, sensitisation and symptoms is not clear. In one cross-sectional study, a close relationship was found between respiratory symptoms and sensitisation 8. However, other studies have shown that a high proportion of work-related symptoms have no allergic basis and are the result of a direct response to a dusty environment 10–15.
The “allergic march” hypothesis originates from cross-sectional studies. However, a recent well performed longitudinal study of bakers apprentices (BA) 16 failed to confirm the allergic march hypothesis.
With this background information, the present authors performed a longitudinal investigation in order to study the sequence of events leading to symptoms, as well as incidences of respiratory symptoms and sensitisation in Danish BA.
MATERIAL AND METHODS
Subjects
The study design has been previously described by Skjold et al. 17. In brief, 347 BA were invited to participate in a study over a 2-yr period. Of these, 197 accepted and 187 participated in the first examination with 114 (61%) undergoing a minimum of one follow-up visit. The initial drop-out rate was mainly related to the inability of the BA to find a baker who would accept them for vocational training.
A methacholine challenge test was performed upon entering and leaving the study. At 4-month intervals spirometry analysis, skin-prick test (SPT) and symptoms were assessed and recorded.
The first visit (inclusion) was carried out during the second school period, when exposure was minimal. The second visit (the first follow-up visit) occurred 4 months after occupational exposure. Seven of the included BA had been exposed for >6 months prior to study recruitment.
After the first visit, the current authors had only a modest drop-out rate and 87 BA attended all follow-up visits up to 20 months (table 1⇓).
The protocol was accepted by the Scientific Ethics Committee of Aarhus (Viborg, Denmark). All subjects gave written informed consent prior to study participation.
Questionnaire
A modification of the European Community Respiratory Health Survey (ECRHS) questionnaire was administered by a physician 18. The BA were asked about the presence and date of onset for the following symptoms that were not related to airways infections during the preceding period: asthma-like symptoms and rhinitis- and/or eye-symptoms. A smoking history was also obtained. The subjects were also asked if their symptoms were aggravated during work. New respiratory symptoms were registered according to the ECRHS protocol 19.
Skin-prick tests
SPT were performed using a standard procedure and recorded after15 min 20. A positive reaction was recorded when the mean of the longest diameter and the mid-point orthogonal diameter of the wheal was ≥3 mm 20. Diluent was used as a negative control and histamine at a concentration of 10 mg·mL−1 was used as a positive control.
Common inhalant allergens (Soluprick ALK; ALK-Abelló®, Hørsholm, Denmark) used were: birch (Betula verruca), grass (Phleum pratense), mugwort (Artemisia vulgaris), horse, cat, dog, two house dust mites (Der P1, Der F1,), Alternaria alternate and Cladosporium herbarum. The occupational allergens in bakeries were in weight per volume: Acarus siro 1:100, Lepidoglyphus destructor 1:100, Aspergillus fumigatus 1:20, wheat 1:20, rye 1:20, oat 1:20, barley 1:20, and mouse 1:100. Extracts reconstituted in the Dept of Respiratory Medicine (Aarhus University Hospital, Aarhus, Denmark) were: Fungamyl® (α-amylase; Novo Nordisk, Bagsvaerd, Denmark) 4 mg·mL−1, Novamyl® (Maltogenic amylase; Novo Nordisk) 4 mg·mL−1, Pentopan™ 500.
(Hemicellulase; Novo Nordisk) 4 mg·mL−1, cockroach (Blatella germanica; ALK-Abelló) 4 mg·mL−1, Mediterranean flour moth (Anagasta kuehniella; ALK-Abelló) 4 mg·mL−1, and Granary weevil (Situphilus granarius; ALK-Abelló) 4 mg·mL−1.
Serum specific and total IgE antibodies
Specific IgE antibodies towards birch, grass, mugwort, horse, dandruff, cat and dog hair, two house dust mites, (Der P1, Der F1,), two storage mites (A. siro, L. destructor), two moulds (A. alternate, A. fumigatus) wheat, rye, oat, barley, mouse, α-amylase, maltogenic amylase, hemicellulase, cockroach (Blatella germanica), flour moth (Anagasta kuehniella), granary weevil (Situphilus granarius) were measured using the in vitro diagnostic kit, Magic Lite®, SQ Allergy. The extracts used were the same as in SPT. Values ≤1.43 SU·mL−1 were regarded as negative. Serum total IgE was measured and a value >150 UI·mL−1 was classified as abnormally high.
Atopy
Atopy was defined as at least one positive SPT reaction to common inhalant allergens with a wheal diameter ≥3 mm.
Lung function testing
Lung function was measured using a dry wedge (Vitalograph-MDI compact®; Vitalograph Ltd, Buckingham, England). The spirometer was calibrated before each session. Predicted values for forced expiratory volume in one second (FEV1) and forced vital capacity (FVC) were computed using normal predicted values from European Community for Coal and Steel 21.
Methacholine challenge test
Bronchial hyperresponsiveness (BHR) was determined using the method of Yan et al. 22 with a Spira Elektro 2® dosimeter (Spira Respiratory Care Center Ltd, Hämeenlinna, Finland) and a maximum cumulated methacholine dose of 1,440 µg. Exclusion criteria for the test were either a predicted FEV1 baseline ≤70% or pregnancy. In these cases a β2-reversibility test was performed. Methacholine test results were expressed either as provocative concentration causing a 20% fall in FEV1 (PD20) or log dose slope, according to standard methods 23.
Diagnostic criteria
Respiratory symptoms are symptoms from the upper and lower airways and include asthma-like symptoms and rhinitis.
Asthma was defined if two of the following asthma-like symptoms were present: attacks of chest tightness; episodes of wheezing; spontaneous episodes of cough or cough after exposure to irritants (cold air, dust, exercise), together with a positive methacholine challenge test (at least 20% decrease in FEV1).
Asthma-like symptoms were defined as any occurrence of the above mentioned symptoms from the lower airways.
Rhinitis was defined if one or more of the classical symptoms of nasal congestion, rhinorrhoea, sneezing or itchy nose were reported and was due to airborne particles. This included at least two of the nasal symptoms on most days 24.
Allergy was defined as a clinical association between being sensitised to an allergen and the development of respiratory symptoms on exposure.
Occupational allergy is defined as a specific allergy to allergens in the occupational setting.
Work-aggravated respiratory symptoms were defined as asthma-like symptoms or rhinitis that became worse in the occupational environment.
Statistical analysis
Statistical analyses were performed using computer software. Rates were calculated as the number of new cases divided by the person-yrs at risk, during the observation period. The p-values were calculated according to Mantel-Haenszel methodology and p-values <0.05 were regarded as significant. Cox regression analyses were performed with person-yrs under observation as the dependent variable and of new asthma-like symptoms, hay fever or eye-symptoms, as the event. Explanatory variables were included simultaneously in this model. Each symptom was treated as a separate entity. Atopy was included as an effect modifier.
RESULTS
From the 114 subjects investigated, 95 remained in the study after 12 months and 87 attended the examination after 20 months. The demographical characteristics of the BA are summarised in table 1⇑. There were no differences in age and sex distribution during the follow-up period.
The prevalence and incidence rates and the cumulative incidence proportion of symptoms, work-aggravated symptoms and SPT were calculated (fig. 1⇓). The cumulative incidence proportion for rhinitis and asthma-like symptoms and SPT were 41.2, 20.5 and 31.1%, respectively, at the 20 month follow-up (fig. 1⇓). The incidence rate of asthma-like, nose and SPT showed peak values at 4 months. The prevalence of SPTs continued to increase slightly (fig. 1e⇓ and f) whereas the prevalence of asthma-like and nose symptoms were almost at the same level during the entire study (fig. 1⇓). The cumulative incidence proportion for nose and asthma-like symptoms showed an increase over time (fig. 1⇓ a–d). The shape of the curve for work aggravated symptoms is paralleling asthma-like symptoms and rhinitis but at a lower level (fig. 1a–d⇓).
The median (range) time for the first symptom to arise from the nose was 237 (180–520) days, from the lower airway was 374 (115–550) days and for new sensitisation by a SPT was 477 (297–644) days. Only one person developed asthma during the follow-up period, according to diagnostic criteria.
The survival ratio (SR) was further analysed in a Cox-regression analysis, to control for confounding in the study of risk factors for the development of symptoms (fig. 2⇓). The current authors found a significant (65%) increased hazard for asthma-like symptoms among the atopic subjects (SR 0.35, (95% confidence interval 0.13–0.93); fig. 2⇓ b and c). Females had a significantly (74%) higher risk for respiratory symptoms 0.26 (0.10–0.69) and 54% risk for work aggravated rhinitis (0.46, 0.23–0.92; fig. 2a⇓ and b). BHR at baseline was associated with the risk of asthma-like symptoms, but not statistically significantly linked.
At the last follow-up visit of the 114 BA, the survival analysis of asthma-like symptoms stratified for SPT and corrected for sex showed 47 had no respiratory symptoms (of which 30 were without symptoms and 17 had symptoms other than the respiratory tract), 31 had rhinitis, 21 had asthma-like symptoms and 15 had both symptoms.
Five BA developed positive SPT to bakery allergens during the study, three developed reactions to wheat and after a 20-month period a further two developed sensitisation as a positive SPT to α-amylase. BA with a positive SPT to α-amylase had asthma-like symptoms and one had rhinitis symptoms as well. Among the three BA positive to wheat flour only one had positive SPT to grass, two of the three were symptomatic.
The number with elevated total IgE (>150 kU·L−1) was much lower than the number with a positive SPT, 16 versus 40 and 10 versus 33 at baseline and the end of follow-up, respectively, and only one BA developed elevated total IgE during the follow-up.
The degree of bronchial responsiveness was not a risk factor for the occurrence of symptoms either when expressed as PD20 or when expressed as having a slope ratio in the highest quartile. BA who developed asthma-like symptoms had a significant increase in BHR after the 20-month follow-up visit (p = 0.006, Kruskal Wallis; fig. 3⇓). Smoking was not a risk factor for the occurrence of airway symptoms.
At baseline 65 BA had no respiratory symptoms. Throughout the follow-up period, 35 BA developed at least one symptom, with nose symptoms as the most frequently reported. Six BA developed two symptoms (two had upper airway and skin symptoms, whilst four had upper and lower airway symptoms). Only two BA developed all three symptoms. A total of 30 BA remained without symptoms.
DISCUSSION
The current study showed that the occurrence of new symptoms from the airways was common among BA. However, this was not paralleled by sensitisation to occupational allergens, which was rare during the 20 months of follow-up.
The present authors found a high incidence of work-related rhinitis symptoms, 22.1 cases·100 person-yrs−1, compared with the recently reported incidences in other groups of bakers and BA varying from 3.6–13.1 cases·100 person-yrs−1 12, 15, 16, 25, 26.
The current authors found 10 cases of asthma-like symptoms per 100 person-yrs, of which all were attributed to the work by the BA. This was in the range of 3.6–17.1 cases·100 person-yrs−1, observed in recent longitudinal studies of BA 16, 25, 27. In the study by De Zotti et al. 25 the incidence of respiratory symptoms was only 3.6 per 100 person-yrs. One explanation for this difference could be that the BA in the study by De Zotti et al. 25 were excluded from further follow-up visits when any symptom occurred, contrary to the current study, where BA were followed for each symptom separately. Another possible explanation could be the frequent follow-up visits during the current study compared with previously performed surveys on BA, with a standardised interview on symptoms and clinical tests, hence, diminishing the risk of recall bias.
The incidence rate for asthma-like symptoms, ∼4 months after training, reached a maximum, thereafter it decreased during the next 8-month period, followed by a new increase, although at a lower rate (fig. 1b⇑). The initial peak has been found earlier 25. This peak could relate to a “harvest phenomenon” i.e. that a large proportion of nonsymptomatic persons in the group develop symptoms immediately after exposure, resulting in a more “resistant” group.
In the multiple regressions analysis, atopy was found as a risk factor for asthma-like symptoms as well as rhinitis, whereas smoking was not classified as a risk factor for the development of symptoms from the airways. The risk of developing airway symptoms was almost doubled among atopics (fig 2b–e⇑) in accordance with a recent study 16. Recently, atopy was found to be a risk factor for occupational allergic rhinitis and bronchial asthma 15, 16. However, other longitudinal studies have not found this relationship 11, 25. It has been argued, that atopy should not be included in the statistical model for evaluation of risk factors since it is an intermediate phase between health and asthma, i.e. (healthy→atopy→asthma) 28. However, the current authors kept the variable in the model, since no relationship was found in the current study’s data.
According to the strict definition given by the current authors only one BA was found to have occupational asthma. However, there is a general problem reaching an agreement on a common definition of asthma in epidemiological studies, which makes comparisons across studies difficult. Hence, a focus on the definition of asthma and rhinitis is needed, as has recently been suggested 29.
BHR at baseline was not a strong risk factor for the development of asthma-like symptoms in accordance with results of Gautrin et al. 15. In that study no significant association between BHR and positive SPT to flour at baseline was found. However, at the 20-month follow-up visit in the present study, a marginally increased risk and an increase in BHR in the BA who developed symptoms during the study was observed. This increase was most likely caused by an inflammatory bronchial reaction as no other explanation, such as bronchial obstruction, was present. Only cases followed until the last follow-up visit were included in the current analysis. Hence the selection bias will tend to underestimate the effect seen in this study.
The present results underpin the seriousness of the development of respiratory symptoms. Even though the BA with respiratory symptoms did not meet the strict criteria for asthma, an inflammatory condition in the airways causing increase in BHR may have developed concomitantly with the occurrence of symptoms.
Although cross sectional studies among bakers have shown a high prevalence of asthma-like symptoms, 10, 30, 31 the relationship between sensitisation and asthma-like symptoms, so far, seems to be unclear 8, 10, 11, 13, 30, 32, 33. Asthma-like symptoms may progress to asthma 34 but the natural history of this symptom in defined populations has not been studied in great detail.
Based on the literature it was expected that the sensitisation rate to the occupational allergens would be high, as cross-sectional studies have established the sensitisation rate between 5–28 and 2–16% for wheat flour and α-amylase, respectively 35. Only a few BA became sensitised to occupational allergens, although a substantial proportion of the participants reported respiratory symptoms. This might reflect a tendency to seek lower exposures among atopics, since no increasing prevalence of SPT towards common allergens throughout the follow-up time was observed.
Also longitudinal studies have been equivocal with respect to a relationship between occupational sensitisation and asthma-like symptoms, some studies have found this relationship 16, 25, whereas other have been unable to do so 12, 15. Exposure and sensitisation to occupational allergens is probably not the primary cause of asthma in this group of young adults. Allergy and asthma may actually develop through separate pathways 36. Atopy but not sensitisation towards occupational allergens was a risk factor for symptoms and could be hypothesised that allergens, apart from occupational allergens or so far uninvestigated allergens, could be responsible. The latter is not a likely explanation, since an extensive range of possible allergens found in bakeries were investigated. However, the current authors’ suggestion is contrary to findings in a recent longitudinal study showing that a positive wheat-SPT was a risk factor for the development of work-related rhino-conjunctivitis 15.
The low sensitisation rate observed in the present study may be caused by a low sensitivity of the SPT extracts and for the specific IgE, as shown previously 37. However, another explanation is that there is no single route leading from exposure through to sensitisation and to symptoms 16. The sequences of events are probably more complex and symptoms may arise independently of sensitisation.
The current longitudinal investigation was planned in order to study the allergic march theory, i.e. the sequence of events leading from initial exposure to symptoms and disease. The allergic march theory anticipates a sequence of sensitisation followed by the manifestation of symptoms in the nose as allergic rhinitis that may progress to asthma 38. Contrary to expectations it was found that asthma-like symptoms and rhinitis appear without a detectable occupational sensitisation, although atopy seemed associated to symptoms. Another recent study of BA also failed to confirm allergic march, as rhinitis occurred before asthma in only 20% of cases and sensitisation was not always preceding symptoms 16. This phenomenon is probably not confined to occupational settings, but may implicate the natural history of allergic disease in general. This may also be the reason why allergy cannot explain and account for asthma as a disease manifestation, even in atopic individuals.
Longitudinal studies are time consuming and difficult to perform especially when young adults are participating and in the current study the initial drop-out rate of 53.4% was almost of the same magnitude as in the previous studies of De Zotti et al. 25 (62.4%), Gautrin 15 (45.2%) and Walusiak et al. 16 (37.7%). The greatest drop-out rate was seen in the study of newly employed bakery and flour mill workers in the UK, where 80% left the study before the end of the 3-yr follow-up period 11. Hence, it is a general problem in this occupational area, especially if the latency period is lengthy 39.
Analyses of the drop-out rates of BA in longitudinal studies are infrequently reported. Walusiak et al. 16 only found health-based selection. The BA in the present study never ascribed leaving the profession to a health problem except for ergonomic problems and the reasons for participants to leave the study was mainly due to factors related to social problems with night-work and employment. However, in an interview 4 months previous to the BA dropping out of the study, 30% reported respiratory symptoms.
The present study found that the occurrence of new respiratory symptoms in BA was high and associated to atopy, being female and increased BHR, but mechanisms other than type 1 mediated allergy seemed to be responsible for this phenomenon. Future research should be directed to identify the responsible mechanism behind this phenomenon, since this is probably of general relevance for the study of asthma and allergy. The design must include a follow-up style investigation and preferably it should be in previously unexposed workers, e.g. baker apprentices or the new expanding group of shop assistants engaged in the finalising of pre-baked bread, as in the study by Cullinan et al. 11. The follow-up should be directed towards the important events occurring at the beginning of employment as shown in the current study. The initial follow-up could then be changed to a more extensive scheme during the following years, allowing enough time (>20 months) for occupational allergies to develop. There are many hurdles to be overcome in longitudinal studies, such as participants dropping out and high costs. However, only with this type of study design will it be possible to learn more about the interaction between all the symptoms and clinical findings comprising of baker’s allergy, asthma and rhinitis and their temporal sequence.
Statement of interest
None declared.
- Received August 18, 2007.
- Accepted March 11, 2008.
- © ERS Journals Ltd